Eton Pharma Reports Its Partner Has Not Received Communication From FDA Related To Decision On Review Of EM-100; Target Action Date Was Aug. 10; Co. Says Is Not Aware Of Any Info Requests Outstanding, Sees FDA Communicating Decision In Coming Days